Latest News

ESC 2026 Hot Line Trials to Watch
Written by: Radcliffe Cardiology
ESC 2026 Hot Line Trials to Watch
KDIGO: Putting CKD at the Heart of CKM Care
Written by: Radcliffe CKM
KDIGO: Putting CKD at the Heart of CKM Care
AI-ECG in Heart Failure: Ready for Clinical Practice?
Written by: Heart Failure Academy
AI-ECG in Heart Failure: Ready for Clinical Practice?
Parallax: Ron Blankstein on the Future of Cardiac CT
Written by: Parallax Episode 160
Parallax: Prof Ron Blankstein on the Future of Cardiac CT
ESC Congress 2026 Hot Line Trials: The Complete Hot Line Trial Guide
Written by: Radcliffe Cardiology
ESC Congress 2026 Hot Line Trials Revealed
Finerenone Approved in EU for HF with LVEF ≥40%
Written by: Heart Failure Academy
Finerenone Approved in EU for HF with LVEF ≥40%
Smartwatch Data Predicts Heart Failure Exacerbations
Written by: CFR Journal
Smartwatch Data Predicts Heart Failure Exacerbations
OPTION-STEMI: Staged Revascularisation for STEMI with HF
Written by: Cardiac Failure Review
OPTION-STEMI: Staged Revascularisation for STEMI with HF
TEER Linked to Better Outcomes in AFMR Patients
Written by: Transcatheter Academy
TEER Linked to Better Outcomes in AFMR Patients
LBBP Superior to BiVP for HF Outcomes in HeartSync-LBBP
Written by: Arrhythmia and Electrophysiology Review
LBBP Superior to BiVP for HF Outcomes in HeartSync-LBBP

External news

Written by: Heart Failure HF
The role of C-reactive protein to lymphocyte ratio and sleep duration in heart failure: exploring the mechanistic interplay and clinical implications
Written by: Academic - open access - HF
Integrating genetics and phenotyping in clinical management of dilated and non-dilated left ventricular cardiomyopathy
Written by: Academic - advance access - HF
Integrating genetics and phenotyping in clinical management of dilated and non-dilated left ventricular cardiomyopathy
Written by: Academic - open access - HF
Long-Term Impact of Aficamten on Patient-Reported Outcome Measures in Obstructive Hypertrophic Cardiomyopathy: Results From FOREST-HCM
Written by: Academic - advance access - HF
Long-Term Impact of Aficamten on Patient-Reported Outcome Measures in Obstructive Hypertrophic Cardiomyopathy: Results From FOREST-HCM
Written by: Academic - advance access - HF
Evaluation and management of heart failure patients with liver disease: European Journal of Heart Failure International Expert Position Paper
Written by: Academic - advance access - HF
Target Versus Below-Target Dose ACE Inhibitors in U.S. Veterans with HFpEF: Differential Outcomes by CKD Status
Written by: Academic - advance access - HF
Catheter ablation in end-stage heart failure with atrial fibrillation: an hierarchical endpoint analysis of the CASTLE-HTx trial
Written by: Academic - open access - HF
Sex Differences in Exercise Training Response Among HFpEF Patients: Pooled Analysis of OptimEx-Clin and Ex-DHF-Trials
Written by: Academic - advance access - HF
Sex Differences in Exercise Training Response Among HFpEF Patients: Pooled Analysis of OptimEx-Clin and Ex-DHF-Trials